Starpharma releases positive DEP® phase 2 interim results in prostate cancer
Starpharma releases positive DEP® phase 2 interim results in prostate cancer
Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of
News story posted on 2021-11-26T07:41:00.0000000Z
Leave a Reply
Want to join the discussion?Feel free to contribute!